Literature DB >> 5783124

Type 3 hyperlipoproteinaemia.

P Borrie.   

Abstract

Eighteen patients with type III hyperlipoproteinaemia, diagnosed on the basis of skin lesions, serum lipids, and lipoprotein electrophoresis, have been fully investigated over a period of 15 years. The incidence of coronary artery disease was only slightly increased, and was not increased at all among first-degree relatives. Peripheral occlusive arterial disease was probably more common. An increased incidence of carbohydrate intolerance was found in neither the patients nor their relatives. The effects of treatment on the skin were uniformly good.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5783124      PMCID: PMC1983670          DOI: 10.1136/bmj.2.5658.665

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  ELEVATION OF SERUM-CHOLESTEROL BY AN ANABOLIC STEROID.

Authors:  P BORRIE
Journal:  Lancet       Date:  1964-04-11       Impact factor: 79.321

2.  Polyacrylamide gels of increasing concentration gradient for the electrophoresis of lipoproteins.

Authors:  J J Pratt; W G Dangerfield
Journal:  Clin Chim Acta       Date:  1969-01       Impact factor: 3.786

3.  Primary hyperlipoproteinemia: the clinico-chemical classification of the most common types.

Authors:  C Pries; C M Van Gent; H Baes; M K Polano; H A Hulsman; A Querido
Journal:  Clin Chim Acta       Date:  1968-02       Impact factor: 3.786

4.  The relationship of serum uric acid to risk factors in coronary heart disease.

Authors:  A R Myers; F H Epstein; H J Dodge; W M Mikkelsen
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

Review 5.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-26       Impact factor: 91.245

6.  Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis.

Authors:  J Slack; N C Nevin
Journal:  J Med Genet       Date:  1968-03       Impact factor: 6.318

7.  STUDIES OF MALE SURVIVORS OF MYOCARDIAL INFARCTION DUE TO "ESSENTIAL" ATHEROSCLEROSIS. 3. CORNEAL ARCUS: INCIDENCE AND RELATION TO SERUM LIPIDS AND LIPOPROTEINS.

Authors:  H M SHANOFF; J A LITTLE
Journal:  Can Med Assoc J       Date:  1964-10-17       Impact factor: 8.262

  7 in total
  7 in total

1.  [Hyperlipoproteinemia and coronary disease. Occurrence, distribution of types, age and sex factors].

Authors:  U H Klemens; P von Löuis of Menar; A Bremer; E von Wnuck; R Schröder
Journal:  Klin Wochenschr       Date:  1972-02-01

2.  Xanthomatosis, hyperlipoproteinaemia (type II, Fredrickson), gout, cardiac infarction.

Authors:  G O Storey
Journal:  Proc R Soc Med       Date:  1971-01

3.  Mutants, hyperlipoproteinaemia, and coronary artery disease.

Authors:  D S Fredrickson
Journal:  Br Med J       Date:  1971-04-24

4.  Cholesterolester accumulation.

Authors:  B J Vermeer; F C Reman
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

5.  Study of the pedigree of a patient with type 3 hyperlipoproteinaemia and sinking prebeta lipoprotein.

Authors:  D Ballantyne; J S Jubb; H G Morgan; T D Lawrie
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

6.  Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

Authors:  Paul N Hopkins; M Nazeem Nanjee; Lily L Wu; Michael G McGinty; Eliot A Brinton; Steven C Hunt; Jeffrey L Anderson
Journal:  Atherosclerosis       Date:  2009-05-22       Impact factor: 5.162

7.  Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.

Authors:  G Feussner; A Wagner; B Kohl; R Ziegler
Journal:  Clin Investig       Date:  1993-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.